275 related articles for article (PubMed ID: 14614522)
1. Potential beneficial as well as detrimental effects of chronic treatment with lisinopril and (or) spironolactone on isolated hearts following low-flow ischemia in normal and infarcted rats.
Rochetaing A; Chapon C; Marescaux L; Le Bouil A; Furber A; Kreher P
Can J Physiol Pharmacol; 2003 Sep; 81(9):864-72. PubMed ID: 14614522
[TBL] [Abstract][Full Text] [Related]
2. Genomic and nongenomic effects of aldosterone in the rat heart: why is spironolactone cardioprotective?
Chai W; Garrelds IM; Arulmani U; Schoemaker RG; Lamers JM; Danser AH
Br J Pharmacol; 2005 Jul; 145(5):664-71. PubMed ID: 15834444
[TBL] [Abstract][Full Text] [Related]
3. Local inhibition of bradykinin degradation in ischemic hearts.
Linz W; Martorana PA; Schölkens BA
J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S99-109. PubMed ID: 1697370
[TBL] [Abstract][Full Text] [Related]
4. Spironolactone improves carotid artery fibrosis and distensibility in rat post-ischaemic heart failure.
Nehme JA; Lacolley P; Labat C; Challande P; Robidel E; Perret C; Leenhardt A; Safar ME; Delcayre C; Milliez P
J Mol Cell Cardiol; 2005 Sep; 39(3):511-9. PubMed ID: 15992819
[TBL] [Abstract][Full Text] [Related]
5. Endothelin-1 increases susceptibility of isolated rat hearts to ischemia/reperfusion injury by reducing coronary flow.
de Groot MC; Illing B; Horn M; Urban B; Haase A; Schnackerz K; Neubauer S
J Mol Cell Cardiol; 1998 Dec; 30(12):2657-68. PubMed ID: 9990537
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of angiotensin I converting enzyme inhibitor on post-ischemic contractile function of perfused rat heart.
Tanonaka K; Kamiyama T; Takezono A; Sakai K; Takeo S
J Mol Cell Cardiol; 1996 Aug; 28(8):1659-70. PubMed ID: 8877776
[TBL] [Abstract][Full Text] [Related]
7. Cardiac-specific effects of parathyroid hormone-related peptide: modification by aging and hypertension.
Ross G; Schlüter KD
Cardiovasc Res; 2005 May; 66(2):334-44. PubMed ID: 15820202
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiological approach of the role of Na+/H+ exchange in low-flow global ischemia and in ischemic preconditioning.
Perchenet L; Rochetaing A; Gallois Y; Kreher P
Can J Physiol Pharmacol; 1997 Feb; 75(2):120-7. PubMed ID: 9114933
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotection with cariporide, a sodium-proton exchanger inhibitor, after prolonged ischemia and reperfusion in senescent rats.
Besse S; Tanguy S; Boucher F; Le Page C; Rozenberg S; Riou B; Leiris Jd; Swynghedauw B
Exp Gerontol; 2004 Sep; 39(9):1307-14. PubMed ID: 15489053
[TBL] [Abstract][Full Text] [Related]
10. Preconditioning with acute and chronic lithium administration reduces ischemia/reperfusion injury mediated by cyclooxygenase not nitric oxide synthase pathway in isolated rat heart.
Faghihi M; Mirershadi F; Dehpour AR; Bazargan M
Eur J Pharmacol; 2008 Nov; 597(1-3):57-63. PubMed ID: 18789320
[TBL] [Abstract][Full Text] [Related]
11. Sivelestat reduces myocardial ischemia and reperfusion injury in rat hearts even when administered after onset of myocardial ischemia.
Kambe M; Bessho R; Fujii M; Ochi M; Shimizu K
Interact Cardiovasc Thorac Surg; 2009 Jun; 8(6):629-34. PubMed ID: 19279053
[TBL] [Abstract][Full Text] [Related]
12. Combined effects of low-dose spironolactone and captopril therapy in a rat model of genetic hypertrophic cardiomyopathy.
de Resende MM; Kriegel AJ; Greene AS
J Cardiovasc Pharmacol; 2006 Dec; 48(6):265-73. PubMed ID: 17204904
[TBL] [Abstract][Full Text] [Related]
13. A comparison between ranolazine and CVT-4325, a novel inhibitor of fatty acid oxidation, on cardiac metabolism and left ventricular function in rat isolated perfused heart during ischemia and reperfusion.
Wang P; Fraser H; Lloyd SG; McVeigh JJ; Belardinelli L; Chatham JC
J Pharmacol Exp Ther; 2007 Apr; 321(1):213-20. PubMed ID: 17202401
[TBL] [Abstract][Full Text] [Related]
14. Effects of lisinopril and captopril on calcium in rat heart.
Wang JF; Xiao WB
Zhongguo Yao Li Xue Bao; 1993 May; 14(3):197-200. PubMed ID: 8237390
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme inhibitors, inhibition of brain and peripheral angiotensin-converting enzymes, and left ventricular dysfunction in rats after myocardial infarction.
Ahmad M; White R; Tan J; Huang BS; Leenen FH
J Cardiovasc Pharmacol; 2008 Jun; 51(6):565-72. PubMed ID: 18496146
[TBL] [Abstract][Full Text] [Related]
16. KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury.
Lee SH; Yang MK; Lim JH; Seo HW; Yi KY; Yoo SE; Lee BH; Won HS; Lee CS; Choi WS; Shin HS
Arch Pharm Res; 2008 Apr; 31(4):482-9. PubMed ID: 18449506
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning.
Serejo FC; Rodrigues LF; da Silva Tavares KC; de Carvalho AC; Nascimento JH
J Cardiovasc Pharmacol; 2007 Apr; 49(4):214-20. PubMed ID: 17438406
[TBL] [Abstract][Full Text] [Related]
18. The role of gender and sex hormones in ischemic-reperfusion injury in isolated rat hearts.
Kuhar P; Lunder M; Drevensek G
Eur J Pharmacol; 2007 Apr; 561(1-3):151-9. PubMed ID: 17335799
[TBL] [Abstract][Full Text] [Related]
19. Trimetazidine improves recovery during reperfusion in isolated rat hearts after prolonged ischemia.
Ikizler M; Dernek S; Sevin B; Kural T
Anadolu Kardiyol Derg; 2003 Dec; 3(4):303-8. PubMed ID: 14675878
[TBL] [Abstract][Full Text] [Related]
20. Dietary polyphenol quercetin protects rat hearts during reperfusion: enhanced antioxidant capacity with chronic treatment.
Ikizler M; Erkasap N; Dernek S; Kural T; Kaygisiz Z
Anadolu Kardiyol Derg; 2007 Dec; 7(4):404-10. PubMed ID: 18065337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
